HHSD2002017M95146B - BLOOD PRODUCTS BPA

This BPA contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2017 on August 02, 2017 to Emory University by Centers for Disease Control and Prevention. There have been $673.7k in obligations to date with a ceiling value of $2M, showing a 34% burn rate so far on the contract. The contract was not competed under any preference program with offers received. We expect a 5 year duration with ultimate completion date of July 30, 2022.

Emory University is a contractor located in GA, doing primarily Pharmaceuticals > Research and Development work for Health and Human Services. The company receives $36.9M annually in federal awards (as of FY2020). Also, they have shown success winning IDC contracts concentrated mainly on a singular customer focused portfolio.

Blanket Purchase Agreements or BPAs establish a method for the Government to satisfy a repetitive need for goods and services. When a government-wide need exists for specific products or services, a BPA allows the Government to establish a single contract to satisfy those needs. Creating a single source for common needs enables the Government to use buying power to drive down prices and avoid the higher costs associated with hundreds or thousands of customers purchasing independently.

Read the full report

Buying Agency/Office

Health and Human Services » Centers for Disease Control and Prevention

Read the full report